P-256 An open-label trial to assess the safety of regorafenib in Turkish patients with metastatic colorectal cancer (mCRC) that progressed on standard therapy (REGARD)

Conference paper > Summary Text

Authors: F. Dane, K. Ozgurdal, S. Yalcin, M. Benekli, N.F. Aykan, I. Yucel, M. Ozkan, T. Evrensel, A. Sevinc, H.S. Coskun, U.S. Sanli, I.O. Kara

Annals of Oncology, , , International, Summary Text, WoS, vol 26, pp iv75-iv75